Despite the significant growth observed in the Nifty FMCG (fast-moving consumer goods) index in 2023, with a rise of 17.5% and reaching new highs, Dabur India Ltd has struggled to gain investor confidence. While the broader sector has performed well, Dabur’s shares have only managed a modest increase of 2.3%. This article examines the factors contributing to Dabur’s subdued performance and explores the company’s growth prospects for the future.
Dabur’s Declining Consolidated EBITDA Margin
During the three months ending in March, Dabur experienced a notable decline in its consolidated EBITDA margin, reaching a multi-quarter low of 15.3%. This decline has raised concerns among investors, who closely monitor the company’s margin performance in the upcoming FY24. Dabur needs help maintaining its margins due to potential currency risks and the need for additional advertising expenditures in response to intensifying competition. While there may be some relief from softening input costs, significant margin improvements are unlikely.
Projections for FY24
Despite the challenges faced by Dabur, Nomura expects the company’s EBITDA margin to show improvement in FY24. They project a year-on-year increase of 127 basis points, bringing the margin to approximately 20%. Considering the current obstacles, this projection provides a glimmer of hope for Dabur.
Promising Growth Outlook for FY24
Dabur’s growth outlook for FY24 appears promising, particularly in the healthcare segment, which constitutes a core aspect of the company’s portfolio. While the healthcare division experienced a relatively weak performance in FY23, with a 7% decline in revenue partly attributable to a high base impact, signs of a rebound are emerging. The sales contribution from this segment to domestic revenue decreased from 36% in FY22 to nearly 32% in FY23. However, with ongoing restructuring efforts and the appointment of Philipe Haydon, former CEO of the Himalaya Drug Company, as the company’s leader, Dabur aims to achieve a high-single to the low double-digit growth rate in FY24.
Transitioning Power Brands and Challenges Ahead
Dabur’s power brands predominantly operate in the healthcare space, where the company enjoys a natural advantage due to its 138-year heritage. Analysts at Nuvama Research have praised Dabur’s strategic initiatives, which involve transitioning power brands to power platforms and expanding their reach across the portfolio. However, Dabur’s dependence on rural market revenue presents a significant challenge, as muted demand poses difficulties. Additionally, the potential development of El Nino further compounds concerns, as it could worsen the recovery slowdown due to hotter summers and weaker monsoons.
Monitoring Performance in Domestic Business
In addition to the healthcare segment, Dabur’s performance in other domestic businesses, specifically home & personal care and foods & beverages, necessitates close monitoring. Nuvama analysts anticipate muted sales in the foods & beverage sector for Q1FY24 due to unseasonal rainfall. Nevertheless, they have adjusted their price-to-earnings multiple for FY25E from 45x to 50x, resulting in a revised target price of ₹705, up from ₹635. As of Wednesday, Dabur’s shares closed at ₹574.10 apiece.
Summary
Despite the growth observed in the Nifty FMCG index, Dabur India Ltd continues to face investor scepticism. Nevertheless, there are indications of a promising growth outlook for FY24, particularly in the healthcare segment, a core aspect of Dabur’s portfolio. However, the company must navigate various challenges, including currency risks, intensifying competition, and the potential impact of El Nino on the recovery process. Investors will closely monitor Dabur’s margin performance and the progress of its domestic businesses to assess the company’s prospects.
Disclaimer: We do not endorse or encourage you to take trades or investment decisions based upon our posts/research, all of your trading and investment activities are your own and should be taken through consultation with reputed financial advisors. The analysis posted on this website has been created by involving multiple mediums which are present over the Internet.